A rally that’s more than doubled shares of Mediterranean fast-casual chain Cava Group Inc. in five months has gone too far, according to its new lone bear on Wall Street. Northcoast Research analyst Jim Sanderson initiated coverage of the restaurant operator this week with a sell rating and a Street-low $63 price target, a day after Cava shares closed at $97.39, the highest level since May 2025, c...
A rally that’s more than doubled shares of Mediterranean fast-casual chain Cava Group Inc. in five months has gone too far, according to its new lone bear on Wall Street. Northcoast Research analyst Jim Sanderson initiated coverage of the restaurant operator this week with a sell rating and a Street-low $63 price target, a day after Cava shares closed at $97.39, the highest level since May 2025, capping a more than 120% run from a late November trough. Sanderson’s target implies a more than 32% decline from where the stock closed Thursday. “The risk profile, given what I see macroeconomically, is unnerving,” Sanderson said in an interview, adding that gains have made shares expensive to own. “The red flag for me was seeing that traffic at some of the mature locations seemed to be very underwhelming, and in many instances, trending negative for several months relative to the peer group.” The run in Cava shares, fueled by a rosy outlook the company gave for the year ahead in late February, is a stark reversal from the nearly 50% drawdown seen in 2025. Investors soured on Cava and fast-casual peers such as Chipotle Mexican Grill Inc. and Sweetgreen Inc. amid concerns about inflation and a slowing economy. The rebound has put Cava stock at a premium to both the broader market and its competitors, a major point of contention on Wall Street. Cava trades at 159 times forward earnings, compared to Chipotle at about 28 times and the S&P 500 Index at nearly 21 times. Cava’s “spicy” valuation limits the stock’s upside going forward, according to DA Davidson analyst Matt Curtis , who initiated coverage on Cava with a neutral rating and $80 price target in March. The stock has 17 buy ratings and 13 holds in addition to Sanderson’s sell, according to data compiled by Bloomberg. A spokesperson for Cava did not respond to a Bloomberg News request for comment. Sanderson does see Cava’s industry-leading new store openings supporting the stock’s high multiple, and says that the firm i...
Ponce Financial (PDLB) delivered earnings and revenue surprises of +33.33% and +13.36%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
Ponce Financial (PDLB) delivered earnings and revenue surprises of +33.33% and +13.36%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
HAMPSTEAD, Md., April 24, 2026 (GLOBE NEWSWIRE) -- Farmers and Merchants Bancshares, Inc. (the “Company”), the parent company of Farmers and Merchants Bank (the “Bank” and, together with the Company, “we”, “us” and “our”), announced that net income for the quarter ended March 31, 2026 was $1.8 million, or $0.56 per common share (basic and diluted), compared to $1.2 million, or $0.37 per common sha...
HAMPSTEAD, Md., April 24, 2026 (GLOBE NEWSWIRE) -- Farmers and Merchants Bancshares, Inc. (the “Company”), the parent company of Farmers and Merchants Bank (the “Bank” and, together with the Company, “we”, “us” and “our”), announced that net income for the quarter ended March 31, 2026 was $1.8 million, or $0.56 per common share (basic and diluted), compared to $1.2 million, or $0.37 per common share (basic and diluted), for the same period in 2025, representing a 57% increase in net income. The Company’s return on average equity during the quarter ended March 31, 2026 was 11.03% compared to 8.22% for the same period in 2025. The Company’s return on average assets during the quarter ended March 31, 2026 was 0.84% compared to 0.57% for the same period in 2025.
JHVEPhoto/iStock Editorial via Getty Images Introduction It hasn't been too long since I last covered defense giant Lockheed Martin Corporation ( LMT ) here on Seeking Alpha, but of course a lot has happened in the meantime (i.e., since late January). In my last article , I gave a preview going into Q4 and full-year 2025 earnings and explained why I am not a seller of LMT stock despite the 30%+ re...
JHVEPhoto/iStock Editorial via Getty Images Introduction It hasn't been too long since I last covered defense giant Lockheed Martin Corporation ( LMT ) here on Seeking Alpha, but of course a lot has happened in the meantime (i.e., since late January). In my last article , I gave a preview going into Q4 and full-year 2025 earnings and explained why I am not a seller of LMT stock despite the 30%+ rebound from recent lows. Although the war in Iran had not yet begun at that point, the military intervention in Venezuela in early January (and, of course, the bombing of Iranian nuclear sites in June 2025 ) were signs that the likelihood of such a scenario was increasing. Considering Lockheed Martin released its Q1 2026 earnings today and results were apparently disappointing (LMT shares are down 5% at the time of writing), it's a good time to give an update on the company's fundamentals. Besides the quarterly results, I'll discuss if anything has changed with regard to the company's long-term outlook against the backdrop of the ongoing war in Iran and generally heightened geopolitical tensions. Finally, I'll give a brief update on valuation, considering LMT shares so far declined almost 25% from their recent—war-induced—all-time high of almost $700. Lockheed Martin: A Disappointing Quarter, But Long-Term Fundamentals Remain Intact For Q1 2026, Lockheed Martin reported earnings per share (EPS) of $6.44, well below the consensus of $6.69 and down 12% year-over-year. Sales of $18.0 billion were basically flat year-over-year, while analysts expected modest growth to the tune of 1%. As illustrated in the segment sales overview in Figure 1, year-over-year declines in sales in the Rotary and Mission Systems (RMS) and Aeronautics segments were offset by higher sales in the Missiles and Fire Control (MFC) and Space segments. Aeronautics, quite understandably, remains the main contributor to sales, although I maintain that Lockheed is indeed very well diversified. Of course, this ap...
svetikd/E+ via Getty Images Intro Our most recent commentary on Healthcare Services Group, Inc. ( HCSG ) was in September of last year, when we stood pat on our 'Hold' rating in the Pennsylvania-based outfit. To recap, HCSG operates in both the Environmental Services and Dietary spaces, where sanitising resident rooms, along with meal preparation, makes up some of their staple services. Our cautio...
svetikd/E+ via Getty Images Intro Our most recent commentary on Healthcare Services Group, Inc. ( HCSG ) was in September of last year, when we stood pat on our 'Hold' rating in the Pennsylvania-based outfit. To recap, HCSG operates in both the Environmental Services and Dietary spaces, where sanitising resident rooms, along with meal preparation, makes up some of their staple services. Our caution 7 months ago stemmed from sustained inflationary pressures, significant overhead, technical resistance, and the lingering impact of the announced Genesis bankruptcy last July, one of HCSG's long-term chief customers. The past three quarters, however, resulted in strong bottom-line beats in both Q3 and Q4 last year, along with the first quarter of FY26, which was announced on the 22nd of February. The company reported GAAP earnings of $0.37 per share for the three months ending on the 31st of March, beating the consensus estimate by an impressive $0.15 per share. Shares spiked on the Q1 earnings release , and it is easy to understand why when one delves into why this stock has transitioned into a long-term 'momentum play.' Financials Continue To Improve Companywide revenue growth on a year-by-year basis is now coming in above 6%, with EBIT growth over the same timeframe surpassing 17%. Given the low margins HCSG has to deal with in its industries, we had already cited that growth (both in terms of revenue and margins) was required in spades to finally move the needle in this stock. Furthermore, we doubted the CEO's comments last year with respect to how Genesis' bankruptcy would remove a cloud over HCSG's growth path and financials, but his assertion has proven to be correct. Case in point: Our previous concerns with respect to rising accounts receivable in HCSH have not come to pass, as the CEO, Theodore Wahl, laid out on the Q1 earnings call below: Continuing to provide services to the Genesis facilities without operational or payment disruption. And we continue to expec...
JHVEPhoto/iStock Editorial via Getty Images Introduction Intel Corporation ( INTC ) delivered mind-blowingly great Q1 results yesterday, showing that the company’s turnaround may take way less time than most of the analysts had predicted earlier. As a result of the good news, together with the overall strong momentum in the semiconductor industry over the last few weeks, the stock trades at about ...
JHVEPhoto/iStock Editorial via Getty Images Introduction Intel Corporation ( INTC ) delivered mind-blowingly great Q1 results yesterday, showing that the company’s turnaround may take way less time than most of the analysts had predicted earlier. As a result of the good news, together with the overall strong momentum in the semiconductor industry over the last few weeks, the stock trades at about $83 per share on the pre-market on Friday, gaining about 25% as I’m writing this article. Intel Pre-Market Even though the company has managed to surprise the market by beating all of the predictions and its own guidance, the jump of 20% post-earnings would mean Nvidia-like ( NVDA ) results, but Intel is still far from the growth levels Nvidia was pulling in its growth era. As a matter of fact, Intel is still growing much slower than all of its peers, including Nvidia, which is a much larger player, making growth harder. I believe Intel shareholders got an early Christmas gift driven by market sentiment, and I would take this gift by selling Intel shares at this all-time high level. It doesn’t mean I don’t believe Intel will grow to these levels in the future. I am positive that it will happen sooner or later, as I’m bullish on the semiconductor industry driven by the AI boom, and Intel is perfectly positioned to be among the winners in the future. But Intel’s operational performance is majorly disconnected from this stock’s valuation, and right now, the risks are way higher than the upside that this stock could reach. The stock could potentially continue rallying, driven by market sentiment, but I wouldn’t bet my money on it. Q1 2026 I believe looking only at this quarter’s earnings, you would miss the bigger picture of why the market reacted the way it did. To better understand what was expected of Intel before, it would be enough to look only one quarter backward. Just a quarter ago, in Q4 2025 , the company reported an earnings beat, but it was far from being “good.” Th...
Since the war in Iran began on Feb. 28, the stock market has been on a roller-coaster ride. The S&P 500 (SNPINDEX: ^GSPC) ended March down over 5%, but has jumped up over 11% since its March 30 bottom for the year (as of market close on April 21). It seems stocks are, unsurprisingly, reacting to whatever flip-flop announcements are coming from the White House regarding the war. And while it can be...
Since the war in Iran began on Feb. 28, the stock market has been on a roller-coaster ride. The S&P 500 (SNPINDEX: ^GSPC) ended March down over 5%, but has jumped up over 11% since its March 30 bottom for the year (as of market close on April 21). It seems stocks are, unsurprisingly, reacting to whatever flip-flop announcements are coming from the White House regarding the war. And while it can be tempting to try to time the market and take advantage of the volatility (it's more luck than skill), smart investors are doing one thing to win. Image source: Getty Images. Continue reading
Dorchester Minerals ( DMLP ) declares $0.475/share quarterly dividend . Forward yield 6.62% Payable May 14; for shareholders of record May 4; ex-div May 4. See DMLP Dividend Scorecard, Yield Chart, & Dividend Growth. More on Dorchester Minerals Dorchester Minerals: Strong Recent Growth In Oil Sales Volumes Dorchester Minerals: Still A Buy, But Beware Of Iran-Driven Risks Dorchester Minerals: Price...
Dorchester Minerals ( DMLP ) declares $0.475/share quarterly dividend . Forward yield 6.62% Payable May 14; for shareholders of record May 4; ex-div May 4. See DMLP Dividend Scorecard, Yield Chart, & Dividend Growth. More on Dorchester Minerals Dorchester Minerals: Strong Recent Growth In Oil Sales Volumes Dorchester Minerals: Still A Buy, But Beware Of Iran-Driven Risks Dorchester Minerals: Price Recovery Makes Sense, Valuation Is Still An Entry Position Top 10 energy stocks showing highest dividend yield as oil crosses $100 mark Dividend scorecard for Dorchester Minerals
Sandisk ( SNDK ) was upgraded to Buy at GF Securities on Friday, with the investment firm putting a $1,277 price target on the stock. Shares rose 2.6% in premarket trading. “SNDK will report FY3Q26 revenue on April 30, and we expect a strong result and guidance given recent upside surprise from consumer electronics,” analyst Yang Zhou wrote in a note to clients. “We see the tightened supply/demand...
Sandisk ( SNDK ) was upgraded to Buy at GF Securities on Friday, with the investment firm putting a $1,277 price target on the stock. Shares rose 2.6% in premarket trading. “SNDK will report FY3Q26 revenue on April 30, and we expect a strong result and guidance given recent upside surprise from consumer electronics,” analyst Yang Zhou wrote in a note to clients. “We see the tightened supply/demand are pushing smartphone makers in taking higher prices to $0.25/GB vs. $0.12 in FY1Q26. For eSSD, we see price negotiations at $0.35-0.37, pushing blended ASP towards 90% QoQ. That said, we forecast SNDK’s FY3Q revenue at $4.9B and margin at 71.5% with FY4Q26 guidance [greater than] $10B and margin [greater than] 84%. We expect another catalyst to be the increase in liabilities, suggesting meaningful down payment of LTAs.” More on Sandisk Corporation Sandisk: A High Beta Play For NAND Memory As AI Demand Surges Sandisk: A Supercycle Is Still A Cycle Sandisk: A High-Growth Buy With A 'Sell The News' Warning For April Intel, AMD benefit from CPU strength, but Morgan Stanley prefers Micron, Sandisk SA analyst upgrades/downgrades: TSLA, AMD, SNDK, AMZN
SEB SA press release ( SEBYF ): Q1 Revenue of €1.88B (-1.6% Y/Y). The Group’s Operating Result from Activity (ORfA) was €72m in the 1 st quarter of 2026, up 42% versus the 1 st quarter of 2025 (€50m). More on SEB SA SEB SA 2026 Q1 - Results - Earnings Call Presentation SEB SA (SEBYY) Q4 2025 Earnings Call Transcript Historical earnings data for SEB SA Dividend scorecard for SEB SA Financial inform...
SEB SA press release ( SEBYF ): Q1 Revenue of €1.88B (-1.6% Y/Y). The Group’s Operating Result from Activity (ORfA) was €72m in the 1 st quarter of 2026, up 42% versus the 1 st quarter of 2025 (€50m). More on SEB SA SEB SA 2026 Q1 - Results - Earnings Call Presentation SEB SA (SEBYY) Q4 2025 Earnings Call Transcript Historical earnings data for SEB SA Dividend scorecard for SEB SA Financial information for SEB SA
Delek Logistics Partners ( DKL ) declares $1.13/share quarterly dividend , 0.4% increase from prior dividend of $1.125. Forward yield 8.78% Payable May 11; for shareholders of record May 4; ex-div May 4. See DKL Dividend Scorecard, Yield Chart, & Dividend Growth. More on Delek Logistics Partners Delek Logistics Partners: Distribution Coverage And Leverage Are Red Flags Delek Logistics: Robust Fund...
Delek Logistics Partners ( DKL ) declares $1.13/share quarterly dividend , 0.4% increase from prior dividend of $1.125. Forward yield 8.78% Payable May 11; for shareholders of record May 4; ex-div May 4. See DKL Dividend Scorecard, Yield Chart, & Dividend Growth. More on Delek Logistics Partners Delek Logistics Partners: Distribution Coverage And Leverage Are Red Flags Delek Logistics: Robust Fundamentals And Valuation May Be Pipelined To More Upside Delek Logistics Partners, LP Common Units (DKL) Q4 2025 Earnings Call Transcript Delek Logistics anticipates $520M–$560M EBITDA in 2026 amid record Q4 performance and Permian growth Delek Logistics Partners GAAP EPS of $0.88 misses by $0.24, revenue of $255.7M misses by $27.94
narvo vexar Organon ( OGN ) shares climbed ~30% in the premarket on Friday after media reports indicated that India’s Sun Pharmaceutical Industries is moving ahead with its biggest-ever M&A deal by submitting a $13B binding offer for the U.S. drugmaker. Mumbai-based Sun Pharma is competing with German drugmaker Grünenthal and Swedish private equity firm EQT for a potential deal, according to the s...
narvo vexar Organon ( OGN ) shares climbed ~30% in the premarket on Friday after media reports indicated that India’s Sun Pharmaceutical Industries is moving ahead with its biggest-ever M&A deal by submitting a $13B binding offer for the U.S. drugmaker. Mumbai-based Sun Pharma is competing with German drugmaker Grünenthal and Swedish private equity firm EQT for a potential deal, according to the story first reported by The Economic Times newspaper in India and later picked up by other local outlets. Shares of the Merck ( MRK ) spinoff have lost ~12% this week, indicating a market capitalization of roughly $2.2B for the company, which had approximately $8.6B in total long- term debt as of Dec. 31 . The stock closed ~28% higher on April 10, after The Economic Times reported that Sun Pharma had submitted a binding offer worth $12B to acquire Organon ( OGN ) in an all-cash transaction. Last week, the paper reported that Sun Pharma and privately held Grünenthal have engaged advisors to submit potential binding bids for the women’s healthcare company in the coming weeks. More on Organon Organon Takeover At $15? Probably Not, Here's Why Organon: Revenue Decline, Margin Pressure, And Strategic Uncertainty Organon & Co. 2025 Q4 - Results - Earnings Call Presentation Organon gains as Sun Pharma, Grünenthal said to seek takeover deals Key deals this week: Organon, UMG, Whitestone REIT, Gilead and more